News
AAVantgarde is now initiating ‘CELESTE’, a first-in-human Phase 1/2 clinical trial in the United States, to evaluate the safety, tolerability, and initial efficacy of AAVB-039 in patients with ...
Similar data from Social Security Scotland indicates there are now 2,010 people receiving ADP for an eye condition. An estimated 188,000 people in Scotland are affected by some form of sight loss with ...
1d
The Healthy @Reader's Digest on MSN16 Possible Causes of Blurry Vision, According to Eye Health ExpertsIt's not only caused by needing corrective lenses. Leading eye doctors share which conditions—big and small—can cause blurry ...
Discover advanced retina treatments at Shreya Eye Centre – the best retina hospital in Noida offering expert care for ...
HOUSTON, TX / ACCESS Newswire / July 9, 2025 / Mann Eye Institute, a leader in innovative eye care since the 1970s, is proud ...
Whether you’re a latte lover, a mocha monster or an espresso elitist — people have strong preferences when it comes to coffee ...
Alcon has inked a deal to acquire LumiThera and its light-based therapy for dry age-related macular degeneration, which ...
Two examples of FDA-approved intracameral implants are Durysta (Allergan) and iDoseTR (Glaukos), both of which provide ...
Streamlined late-stage clinical and pre-commercial organization aligns with focused pipeline shift, as announced in January 2025 ...
This discovery could make treatment for an eye disease affecting millions with diabetes more accessible and affordable.
Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results